Attached files
| file | filename |
|---|---|
| 10-K - QUARTERLY REPORT - EVOLUTIONARY GENOMICS, INC. | fnam_10k.htm |
| EX-32.1 - CERTIFICATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex32z1.htm |
| EX-21.1 - SUBSIDIARIES - EVOLUTIONARY GENOMICS, INC. | fnam_ex21z1.htm |
| EX-10.9 - AGREEMENT AMENDMENT #1 - EVOLUTIONARY GENOMICS, INC. | fnam_ex10z9.htm |
| EX-10.10 - AGREEMENT AMENDMENT #2 - EVOLUTIONARY GENOMICS, INC. | fnam_ex10z10.htm |
| EX-31.1 - CERTIFICATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex31z1.htm |
| EX-31.2 - CERTIFICATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex31z2.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Evolutionary Genomics, Inc. (the "Company") on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve B Warnecke, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
BY: | /s/ Steve B Warnecke |
| Steve B Warnecke |
| Chief Financial Officer |
| (principal financial officer) |
| February 10, 2017 |